Oranan Siwamogsatham1, Jessica A Alvarez, Vin Tangpricha. 1. aDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine bSamitivej Srinakarin Hospital, Bangkok Hospital Group, Bangkok, Thailand cEmory Adult Cystic Fibrosis Program, Emory Healthcare dSection of Endocrinology, Atlanta VA Medical Center, Decatur, Georgia, USA.
Abstract
PURPOSE OF REVIEW: The aim of this review is to provide an update on various relevant endocrine aspects of care in adolescents and adults with cystic fibrosis. RECENT FINDINGS: As life expectancy in cystic fibrosis has continuously improved, endocrine complications have become more apparent. The common endocrine complications include cystic fibrosis related diabetes, cystic fibrosis related bone disease, vitamin D deficiency and poor growth and pubertal development. Thyroid and adrenal disorders have also been reported, although the prevalence appears to be less common. SUMMARY: Endocrine diseases are an increasingly recognized complication that has a significant impact on the overall health of individuals with cystic fibrosis. This review summarizes the updated screening and management of endocrine diseases in the cystic fibrosis population.
PURPOSE OF REVIEW: The aim of this review is to provide an update on various relevant endocrine aspects of care in adolescents and adults with cystic fibrosis. RECENT FINDINGS: As life expectancy in cystic fibrosis has continuously improved, endocrine complications have become more apparent. The common endocrine complications include cystic fibrosis related diabetes, cystic fibrosis related bone disease, vitamin D deficiency and poor growth and pubertal development. Thyroid and adrenal disorders have also been reported, although the prevalence appears to be less common. SUMMARY:Endocrine diseases are an increasingly recognized complication that has a significant impact on the overall health of individuals with cystic fibrosis. This review summarizes the updated screening and management of endocrine diseases in the cystic fibrosis population.
Authors: Amanda L Brennan; Khin M Gyi; David M Wood; Margaret E Hodson; Duncan M Geddes; Emma H Baker Journal: J Cyst Fibros Date: 2005-09-30 Impact factor: 5.482
Authors: V Tangpricha; A Kelly; A Stephenson; K Maguiness; J Enders; K A Robinson; B C Marshall; D Borowitz Journal: J Clin Endocrinol Metab Date: 2012-03-07 Impact factor: 5.958
Authors: Moon Jeong Lee; Jessica A Alvarez; Ellen M Smith; David W Killilea; James F Chmiel; Patricia M Joseph; Ruth E Grossmann; Amit Gaggar; Thomas R Ziegler; Vin Tangpricha Journal: Nutr Clin Pract Date: 2015-06-15 Impact factor: 3.080
Authors: Vin Tangpricha; Joshua Lukemire; Yuqing Chen; José Nilo G Binongo; Suzanne E Judd; Ellen S Michalski; Moon J Lee; Seth Walker; Thomas R Ziegler; Rabin Tirouvanziam; Susu M Zughaier; Supavit Chesdachai; Wendy A Hermes; James F Chmiel; Ruth E Grossmann; Amit Gaggar; Patricia M Joseph; Jessica A Alvarez Journal: Am J Clin Nutr Date: 2019-03-01 Impact factor: 7.045
Authors: Vin Tangpricha; Ellen M Smith; Jose Binongo; Suzanne E Judd; Thomas R Ziegler; Seth Walker; Rabindra Tirouvanziam; Susu M Zughaier; Moon Jeong Lee; Supavit Chesdachai; Wendy A Hermes; James F Chmiel; Amit Gaggar; Ruth E Grossmann; Patricia M Joseph; Jessica A Alvarez Journal: Contemp Clin Trials Commun Date: 2017-03-09
Authors: Cecilia Catellani; Francesca Cirillo; Sara Graziano; Luisa Montanini; Nelson Marmiroli; Mariolina Gullì; Maria Elisabeth Street Journal: Acta Biomed Date: 2022-07-01